Lynn El Haddad1, Blake M Hanson2,3, Cesar A Arias2,3,4, Shashank S Ghantoji5, Cynthia P Harb5, Mark Stibich5,6, Roy F Chemaly5. 1. Department of Medicine, University of Florida, Gainesville, Florida, USA. 2. Center for Antimicrobial Resistance and Microbial Genomics and Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, Texas, USA. 3. Center for Infectious Diseases, UTHealth School of Public Health, Houston, Texas, USA. 4. Molecular Genetics and Antimicrobial Resistance Unit-International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia. 5. Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 6. Xenex Disinfection Services, San Antonio, Texas, USA.
Abstract
BACKGROUND: Vancomycin-resistant enterococci (VRE) are a major cause of morbidity and mortality in immunocompromised patients. Tracking the dissemination of VRE strains is crucial to understand the dynamics of emergence and spread of VRE in the hospital setting. METHODS: Whole genome sequencing (WGS) and phylogenetic analyses were performed to identify dominant VRE strains and potential transmission networks between 35 patients with VRE-positive rectal swabs and their rooms (main rooms and bathrooms) on the leukemia (LKM) and the hematopoietic cell transplant (HCT) floors. Sequence types (STs), drug resistance genes, and patients' outcomes were also determined. RESULTS: A total of 89 VRE strains grouped into 10 different STs, of which newly described STs were isolated from both floors (ST736, ST494, ST772, and ST1516). We observed highly genetically related strains transmitted between rooms, floors, and time periods in an average period of 39 days (ranging from 3 to 90 days). Of 5 VRE bacteremia events, 3 strains were lacking the pili operon fms14-17-13 (ST203) and the remaining 2 were resistant to daptomycin (DAP; ST736, ST664). Of 10 patients harboring DAP-resistant strains, only 2 were exposed to DAP within 4 months before strain recovery. CONCLUSIONS: Our comparisons of VRE strains derived from the environment and immunocompromised patients confirmed horizontal transfer of highly related genetic lineages of multidrug-resistant (particularly to DAP) VRE strains between HCT and LKM patients and their room environment. Implementing WGS can be useful in distinguishing VRE reservoirs where interventions can be targeted to prevent and control the spread of highly resistant organisms.
BACKGROUND: Vancomycin-resistant enterococci (VRE) are a major cause of morbidity and mortality in immunocompromised patients. Tracking the dissemination of VRE strains is crucial to understand the dynamics of emergence and spread of VRE in the hospital setting. METHODS: Whole genome sequencing (WGS) and phylogenetic analyses were performed to identify dominant VRE strains and potential transmission networks between 35 patients with VRE-positive rectal swabs and their rooms (main rooms and bathrooms) on the leukemia (LKM) and the hematopoietic cell transplant (HCT) floors. Sequence types (STs), drug resistance genes, and patients' outcomes were also determined. RESULTS: A total of 89 VRE strains grouped into 10 different STs, of which newly described STs were isolated from both floors (ST736, ST494, ST772, and ST1516). We observed highly genetically related strains transmitted between rooms, floors, and time periods in an average period of 39 days (ranging from 3 to 90 days). Of 5 VRE bacteremia events, 3 strains were lacking the pili operon fms14-17-13 (ST203) and the remaining 2 were resistant to daptomycin (DAP; ST736, ST664). Of 10 patients harboring DAP-resistant strains, only 2 were exposed to DAP within 4 months before strain recovery. CONCLUSIONS: Our comparisons of VRE strains derived from the environment and immunocompromised patients confirmed horizontal transfer of highly related genetic lineages of multidrug-resistant (particularly to DAP) VRE strains between HCT and LKM patients and their room environment. Implementing WGS can be useful in distinguishing VRE reservoirs where interventions can be targeted to prevent and control the spread of highly resistant organisms.
Authors: Sebastian Scheich; Sarah Lindner; Rosalie Koenig; Claudia Reinheimer; Thomas A Wichelhaus; Michael Hogardt; Silke Besier; Volkhard A J Kempf; Johanna Kessel; Hans Martin; Anne C Wilke; Hubert Serve; Gesine Bug; Björn Steffen Journal: Cancer Date: 2017-09-28 Impact factor: 6.860
Authors: Sebastiaan J van Hal; Camilla L C Ip; M Azim Ansari; Daniel J Wilson; Bjorn A Espedido; Slade O Jensen; Rory Bowden Journal: Microb Genom Date: 2016-01-19
Authors: Guiqing Wang; Fan Yu; Henry Lin; Karthikeyan Murugesan; Weihua Huang; Andrew G Hoss; Abhay Dhand; Leslie Y Lee; Jian Zhuge; Changhong Yin; Marisa Montecalvo; Nevenka Dimitrova; John T Fallon Journal: PLoS One Date: 2018-12-21 Impact factor: 3.240
Authors: Jeremy C Storm; Daniel J Diekema; Jennifer S Kroeger; Sarah J Johnson; Birgir Johannsson Journal: Antimicrob Resist Infect Control Date: 2012-05-29 Impact factor: 4.887
Authors: Adeline Supandy; Heer H Mehta; Truc T Tran; William R Miller; Rutan Zhang; Libin Xu; Cesar A Arias; Yousif Shamoo Journal: Antimicrob Agents Chemother Date: 2022-05-11 Impact factor: 5.938
Authors: Lynn El Haddad; Georgios Angelidakis; Justin R Clark; Jesus F Mendoza; Austen L Terwilliger; Christopher P Chaftari; Mark Duna; Serena T Yusuf; Cynthia P Harb; Mark Stibich; Anthony Maresso; Roy F Chemaly Journal: Pharmaceutics Date: 2022-07-30 Impact factor: 6.525